User profiles for "author:Thomas Gattringer"

Thomas Gattringer

Neurologist, Medical University of Graz
Verified email at medunigraz.at
Cited by 5354

Neurofilaments as biomarkers in neurological disorders

M Khalil, CE Teunissen, M Otto, F Piehl… - Nature Reviews …, 2018 - nature.com
Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage …

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb… - The Lancet, 2020 - thelancet.com
Background Patients who have had a stroke with unknown time of onset have been
previously excluded from thrombolysis. We aimed to establish whether intravenous …

Early versus later anticoagulation for stroke with atrial fibrillation

U Fischer, M Koga, D Strbian, M Branca… - … England Journal of …, 2023 - Mass Medical Soc
Background The effect of early as compared with later initiation of direct oral anticoagulants
(DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear …

Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia

MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - jamanetwork.com
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …

Access to and delivery of acute ischaemic stroke treatments: a survey of national scientific societies and stroke experts in 44 European countries

D Aguiar de Sousa, R von Martial… - European stroke …, 2019 - journals.sagepub.com
Introduction Acute stroke unit care, intravenous thrombolysis and endovascular treatment
significantly improve the outcome for patients with ischaemic stroke, but data on access and …

European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment

TJ Quinn, E Richard, Y Teuschl… - European stroke …, 2021 - journals.sagepub.com
The optimal management of post-stroke cognitive impairment remains controversial. These
joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) …

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial

M Bendszus, J Fiehler, F Subtil, S Bonekamp… - The Lancet, 2023 - thelancet.com
Background Recent evidence suggests a beneficial effect of endovascular thrombectomy in
acute ischaemic stroke with large infarct; however, previous trials have relied on multimodal …

[HTML][HTML] Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

D Wilson, G Ambler, KJ Lee, JS Lim… - The Lancet …, 2019 - thelancet.com
Background Cerebral microbleeds are a neuroimaging biomarker of stroke risk. A crucial
clinical question is whether cerebral microbleeds indicate patients with recent ischaemic …

Serum neurofilament light is sensitive to active cerebral small vessel disease

T Gattringer, D Pinter, C Enzinger, T Seifert-Held… - Neurology, 2017 - AAN Enterprises
Objective: To explore whether serum neurofilament light chain protein (NfL) levels are
increased in patients with MRI-confirmed recent small subcortical infarcts (RSSI) compared …

[HTML][HTML] Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

RAS Salman, MS Dennis, PAG Sandercock… - The Lancet, 2019 - thelancet.com
Background Antiplatelet therapy reduces the risk of major vascular events for people with
occlusive vascular disease, although it might increase the risk of intracranial haemorrhage …